Neoleukin Therapeutics Inc Stock Predictions

NASDAQ Stock Exchange > Healthcare > Drug Manufacturers—Specialty & Generic

Open Broker Account

$3.49

+0 (+0%)

At Close: Mar 15, 2024

Currently predicting for Wed, 8 May 2024

NLTX Predictions History

BE THE FIRST TO PREDICT

The excellent way of becoming a better trader

Easy to use
Enhance your skills
Predict as many as you like
Request predictions
Gather points

Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

About Neoleukin Therapeutics Inc

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aqui... NLTX Profile

Golden Star

Ticker	Date	Change	Price
TMO	May 02	0.403%	$571.25
STNG	May 02	0.699%	$71.50
DLR	May 02	2.58%	$140.15
RF	May 02	0.97%	$19.64
INVH	May 02	0.87%	$34.50
SMAR	May 02	2.24%	$38.39
BIRK	May 02	0.650%	$44.61
FTSL	May 02	0.217%	$46.11
VCSH	May 02	0.287%	$76.71
VRNT	May 02	2.44%	$30.78

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In